Division of Nephrology, Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington; Veteran Affairs Health Services Research and Development Center of Innovation for Veteran-Centered and Value-Driven Care, Seattle, Washington.
Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Bioinformatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Am J Kidney Dis. 2024 Nov;84(5):646-650. doi: 10.1053/j.ajkd.2024.03.017. Epub 2024 Apr 24.
Advocates for improved equity in kidney transplants in the United States have recently focused their efforts on initiatives to increase referral for transplant evaluation. However, because donor kidneys remain scarce, increased referrals are likely to result in an increasing number of patients proceeding through the evaluation process without ultimately receiving a kidney. Unfortunately, the process of referral and evaluation can be highly resource-intensive for patients, families, transplant programs, and payers. Patients and families may incur out-of-pocket expenses and be required to complete testing and treatments that they might not have chosen in the course of routine clinical care. Kidney transplant programs may struggle with insufficient capacity, inefficient workflow, and challenging programmatic finances, and payers will need to absorb the increased expenses of upfront pretransplant costs. Increased referral in isolation may risk simply transmitting system stress and resulting disparities to downstream processes in this complex system. We argue that success in efforts to improve access through increased referrals hinges on adaptations to the pretransplant process more broadly. We call for an urgent re-evaluation and redesign at multiple levels of the pretransplant system in order to achieve the aim of equitable access to kidney transplantation for all patients with kidney failure.
美国提倡在肾脏移植中实现更高的公平性,最近将重点放在增加移植评估转诊的举措上。然而,由于供体肾脏仍然稀缺,增加转诊可能会导致越来越多的患者在没有最终获得肾脏的情况下通过评估过程。不幸的是,转诊和评估过程对患者、家庭、移植项目和支付方来说可能需要大量资源。患者和家庭可能会产生自付费用,并需要完成他们在常规临床护理过程中可能不会选择的检查和治疗。肾脏移植项目可能会面临能力不足、工作流程效率低下和具有挑战性的项目财务状况,而支付方将需要承担增加的前期移植费用。单纯增加转诊可能会导致系统压力传递和下游过程中的差异,从而增加系统的复杂性。我们认为,通过增加转诊来改善获得肾脏移植的机会,关键在于更广泛地适应移植前的过程。我们呼吁在移植前系统的多个层面上紧急重新评估和重新设计,以实现所有肾衰竭患者公平获得肾脏移植的目标。